Progression in Teratocarcinomas
One of the joys of preparing this paper was the necessity of rereviewing the elegant work of Leslie Foulds (1969), Harry Greene (1951), and Jacob Furth (1953), and of recalling many pleasant and stimulating discussions with each of them. Foulds studied solid tumors, primarily adenocarcinomas of the breast, and his definition of progression as the independent and irreversible gain or loss of unit characters with time leading to the autonomous state has served oncologists well. Similarly, Greene’s study of adenocarcinoma of the endometrium and breast which demonstrated increased malignancy with time are classics, and Furth’s demonstration of conditioned and dependent tumors and loss of dependency as a manifestation of progression has markedly influenced endocrine therapy of cancer. The mechanism of progression appears to involve the selection of cells best able to survive under the conditions. Thus, the irreversible gains and losses of attributes by a tumor with time are the result of extermination of subpopulations of cells with consequent loss of their phenotypic traits, leaving a tumor composed of more rapidly growing subpopulations expressing their particular traits. Thus, the phenotype and behavior of tumors change irreversibly with time.
KeywordsEmbryoid Body Embryonal Carcinoma Chimeric Mouse Embryonal Carcinoma Cell Stem Line
Unable to display preview. Download preview PDF.
- Becker, K. L., 1984, The endocrine lung, in: “The Endocrine Lung in Health & Disease,” K. L. Becker and A. F. Gasdar, eds., W. B. Saunders Co., Philadelphia.Google Scholar
- Foulds, L., 1969, “Neoplastic Development,” Vol. 1, Academic Press, 1969.Google Scholar
- Lewison, E. F. (ed.), 1976, Conference on Spontaneous Regression of Cancer, Natl. Cancer Inst. Monogr., 44:1–150.Google Scholar
- Monzo, M., Andres, X., and Ruano-Gil, D., 1983, Etude morphologique d’une population homogene de cellules de terato-carcinome, Bulletin De L’Association Des Anatomistes, 67:91–98.Google Scholar
- Nowell, P. C., 1982, Genetic instability in cancer cells: Relationship to tumor cell heterogeneity, in: “Tumor Cell Heterogeneity”, A. H. Owens, D. S. Coffey, and S. B. Baylin, eds., Academic Press, New York.Google Scholar
- Parchment, R. E., Damjanov, A., Damjanov, I., Gramzinski, R. A., and Pierce, G. B., 1989, Neoplastic embryoid bodies of embryonal carcinoma as a source of blastocele fluid, in preparation.Google Scholar
- Pierce, G. B., 1967, Teratocarcinoma: Model for a developmental concept of cancer, in: “Current Topics in Developmental Biology,” Vol. 2, A. A. Moscona and A. Monroy, eds., Academic Press, New York.Google Scholar
- Pierce, G. B., Lewellyn, A., and Parchment, R. E., 1989, Detection of different regulatory mechanisms for subpopulations of embryonal carcinoma and inner cell mass cells in the mouse blastocyst, in preparation.Google Scholar
- 1.Papaioannou, V. E., Gardner, R. L., McBurney, M. W., Babinet, C. and Evans, M. J., Participation of cultured teratocarcinoma cells in mouse embryogenesis. J. Embryol. Exp. Morph., 44:93–104, 1978.Google Scholar
- 2.Papaioannou, V. E., Evans, E. P., Gardner, R. L. and Graham, C. F., Growth and differentiation of an embryonal carcinoma cell line (C145b). J. Exp. Morph. 54:277–295, 1979.Google Scholar
- 3.Illmensee, K., Reversion of malignancy and normalized differentiation of teratocarcinoma cells in chimeric mice. In, Genetic Mosaics and Chimeras in Mammals. L. B. Russell, Ed., pp. 3–25, Plenum, New York, 1978.Google Scholar